Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 578

2.

C-reactive protein and coronary heart disease in western Turkey.

Onat A, Sansoy V, Yildirim B, Keleş I, Uysal O, Hergenç G.

Am J Cardiol. 2001 Sep 15;88(6):601-7.

PMID:
11564380
3.

[Study on C-reactive protein and the risk factors of traditional coronary heart disease].

Guo ZR, Hu XS, Chen FM, Wu M.

Zhonghua Liu Xing Bing Xue Za Zhi. 2007 Nov;28(11):1064-8. Chinese.

PMID:
18396656
4.

Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population.

Hung J, Knuiman MW, Divitini ML, Davis T, Beilby JP.

Am J Cardiol. 2008 Jan 15;101(2):193-8. doi: 10.1016/j.amjcard.2007.07.061.

PMID:
18178405
5.

C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.

Cushman M, Arnold AM, Psaty BM, Manolio TA, Kuller LH, Burke GL, Polak JF, Tracy RP.

Circulation. 2005 Jul 5;112(1):25-31. Epub 2005 Jun 27.

6.

Cross-sectional study of complement C3 as a coronary risk factor among men and women.

Onat A, Uzunlar B, Hergenç G, Yazici M, Sari I, Uyarel H, Can G, Sansoy V.

Clin Sci (Lond). 2005 Feb;108(2):129-35.

PMID:
15487975
7.
8.

Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men.

Goldbourt U, Yaari S, Medalie JH.

Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):107-13.

9.

Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.

Wilt TJ, Rubins HB, Collins D, O'Connor TZ, Rutan GH, Robins SJ.

Arch Intern Med. 1996 Jun 10;156(11):1181-8.

PMID:
8639012
10.

Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.

Dupuy AM, Jaussent I, Lacroux A, Durant R, Cristol JP, Delcourt C.

Gerontology. 2007;53(6):329-39. Epub 2007 Jun 5.

PMID:
17551260
11.

Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome.

Santos AC, Lopes C, Guimarães JT, Barros H.

Int J Obes (Lond). 2005 Dec;29(12):1452-6.

PMID:
16077717
13.

The associations between current recommendation for physical activity and cardiovascular risks associated with obesity.

Akbartabartoori M, Lean ME, Hankey CR.

Eur J Clin Nutr. 2008 Jan;62(1):1-9. Epub 2007 Mar 7.

PMID:
17342166
14.

Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study.

Seman LJ, DeLuca C, Jenner JL, Cupples LA, McNamara JR, Wilson PW, Castelli WP, Ordovas JM, Schaefer EJ.

Clin Chem. 1999 Jul;45(7):1039-46.

15.

C-reactive protein distribution and correlates among men and women with chronic coronary heart disease.

Benderly M, Haim M, Boyko V, Tanne D, Behar S, Matas Z, Zimlichman R, Goldbourt U.

Cardiology. 2007;107(4):345-53. Epub 2007 Feb 1.

PMID:
17283424
16.

Abdominal obesity and the spectrum of global cardiometabolic risks in US adults.

Ghandehari H, Le V, Kamal-Bahl S, Bassin SL, Wong ND.

Int J Obes (Lond). 2009 Feb;33(2):239-48. doi: 10.1038/ijo.2008.252. Epub 2008 Dec 9.

PMID:
19050677
17.
18.

Rationale for targeted rather than population based screening with C-reactive protein using the National Health and Nutrition Examination Survey (1999 to 2002).

Guttormsen BN, Stein JH, McBride PE, Cullen MW, Gangnon R, Keevil JG.

Am J Cardiol. 2007 Oct 1;100(7):1130-3. Epub 2007 Jul 18.

PMID:
17884376
19.
20.

Relative importance of borderline and elevated levels of coronary heart disease risk factors.

Vasan RS, Sullivan LM, Wilson PW, Sempos CT, Sundström J, Kannel WB, Levy D, D'Agostino RB.

Ann Intern Med. 2005 Mar 15;142(6):393-402. Erratum in: Ann Intern Med. 2005 Apr 19;142(8):681.

PMID:
15767617

Supplemental Content

Support Center